DE & 45 states expand price-fixing lawsuit against drug manufacturers


The Delaware Attorney General along with other state Attorneys General are expanding a lawsuit against generic prescription drug manufacturers for illegal price-fixing agreements. The lawsuit alleges 18 companies illegally agreed to fix prices and divvy up customers for generic antibiotics and drugs that treat epilepsy, high blood pressure, and asthma.  It also claims that the agreements were part of a broader, overarching industry code of conduct assigning competitors specific shares of the market. Delaware Attorney General Matt Denn says 88% of prescriptions in the US are generic drugs, and this collusion has resulted in artificially inflated prices for generic drugs, which impact government and private healthcare costs.